Postoperative Pain Management Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
Market Players Eyeing Growth Opportunities in Asia and MEA as Opioid Concerns Rise
The global market for postoperative pain management is poised for significant growth, with a valuation of US$ 37 billion in 2024 and a projected Compound Annual Growth Rate (CAGR) of 7% to reach US$ 57.8 billion by 2031.
Rising Demand for Pain Management Drugs
One of the key drivers of market growth is the increasing prevalence of chronic diseases and a growing number of surgical procedures worldwide. The National Health statistics report that the U.S. alone witnesses 100 million surgeries annually, contributing significantly to the consumption of pain management drugs. Additionally, the rising incidence of cancer therapy-associated pain and an aging population undergoing various surgeries are fueling market expansion.
Impact of Road Accidents on Market Growth
The market is also expected to benefit from the increasing number of road accidents globally. Trauma injuries resulting from accidents often lead to high levels of pain, making postoperative pain management essential. Key players are ramping up their production to meet the demand arising from these incidents, contributing positively to market growth.
Focus on Abuse-Deterrent Opioids and Non-Opioid Drugs
Furthermore, the market is witnessing a surge in demand for painkiller drugs due to an increasing focus on the development of abuse-deterrent opioid drugs and extended-release non-opioid drugs for post-surgery pain management. Increased awareness of post-surgery pain control, coupled with the development and commercialization of non-narcotic drugs and non-abuse opioids, is supplementing market growth.
Opportunities in Asia and MEA
While opioids remain commonly used for postoperative pain management in North America and Europe, concerns about their non-medical use have led governing bodies to encourage the prescription of non-opioid drugs. This shift presents opportunities for companies to introduce novel non-opioid drugs in these regions. In contrast, Asia and Africa face a lack of efficient postoperative pain management medications, creating potential growth opportunities for market players.
Challenges to Market Expansion
However, market growth faces challenges, including growing concerns about the opioid epidemic and the increasing cost burden of pain management on reimbursement providers. Adverse side effects associated with excessive intake of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and opioids, as well as limited availability of postoperative pain management drugs in certain regions, are hindering market growth.
Country-Wise Insights
• U.S. - A Strong Market: The U.S. is a significant market for postoperative pain management, primarily due to its robust pipeline of postoperative pain management drugs and efforts to combat the opioid epidemic. The adoption of opioid management treatments is expected to reduce opioid-related issues. Additionally, the U.S. has a strong drug pipeline, with new and effective drugs seeking approval from the U.S. Food and Drug Administration, further driving the use of postoperative pain management drugs.
• Germany - Leading in Europe: Germany is a lucrative market for postoperative pain management in Europe. This is attributed to the high incidence and severity of postoperative pain in the country, the introduction of promising drugs, an increasing number of surgical procedures, and a high rate of pain management procedures. The acceptance of Opioid Maintenance Treatment (OMT) for opioid dependence in Germany is also a significant factor boosting the demand for postoperative pain management drugs.
• China - Rapid Growth: In China, the demand for postoperative pain management medication is being fueled by a high number of surgeries being performed in the country. Numerous pain management drug manufacturers are engaging in distribution agreements, partnerships, and launching postoperative pain management medications, particularly in the Asia Pacific region, with China at the forefront of this growth.
Competitive Analysis
Leading suppliers of postoperative pain management medicines are focusing on collaborations and acquisitions with pharmaceutical companies to develop novel product lines for pain management.
Key Companies Profiled:
• Teva Pharmaceutical Industries Ltd.
• Novartis AG
• Allergan plc
• Mylan N.V.
• Pfizer Inc.
• Purdue Pharma L.P.
• Janssen Pharmaceuticals, Inc.
• Endo International plc.
• Pacira Pharmaceuticals Inc.
• Egalet Corporation
• GlaxoSmithKline Plc.
Postoperative Pain Management Industry Survey by Category
Postoperative Pain Management Market by Drug Class:
• Opioids
• NSAIDs
• Local Anesthetic
• Acetaminophen
Postoperative Pain Management Market by Route of Administration:
• Injectable Postoperative Pain Management
• Oral Postoperative Pain Management
• Topical Postoperative Pain Management
• Transdermal Postoperative Pain Management
• Others
Postoperative Pain Management Market by Distribution Channel:
• Hospital Pharmacies
• Retail Pharmacies
• Drug Stores
• Clinics
• Others
Postoperative Pain Management Market by Region:
• North America Postoperative Pain Management Market
• Latin America Postoperative Pain Management Market
• Europe Postoperative Pain Management Market
• East Asia Postoperative Pain Management Market
• South Asia Postoperative Pain Management Market
• Oceania Postoperative Pain Management Market
• The Middle East and Africa (MEA) Postoperative Pain Management Market
Please note: The PDF e-mail from publisher version of this report is for a global site license. Delivery Timelines - 5 working days.